Boersma HH - Search Results

1

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine.

Alleva DG, Feitsma EA, Janssen YF, Boersma HH, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, Ronca SE, Green FM, Shaw SA, Aminetzah A, Kruijff S, Brom M, van Dam GM, Zion TC. Alleva DG, et al. Among authors: boersma hh. NPJ Vaccines. 2024 Feb 21;9(1):40. doi: 10.1038/s41541-024-00830-2. NPJ Vaccines. 2024. PMID: 38383578 Free PMC article.

2

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.

Janssen YF, Feitsma EA, Boersma HH, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, Ronca SE, Green FM, Aminetzah A, Sollie F, Kruijff S, Brom M, van Dam GM, Zion TC. Janssen YF, et al. Among authors: boersma hh. Vaccine. 2022 Feb 23;40(9):1253-1260. doi: 10.1016/j.vaccine.2022.01.043. Epub 2022 Jan 31. Vaccine. 2022. PMID: 35115195 Free PMC article. Clinical Trial.

3

Targeted optical fluorescence imaging: a meta-narrative review and future perspectives.

Schouw HM, Huisman LA, Janssen YF, Slart RHJA, Borra RJH, Willemsen ATM, Brouwers AH, van Dijl JM, Dierckx RA, van Dam GM, Szymanski W, Boersma HH, Kruijff S. Schouw HM, et al. Among authors: boersma hh. Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4272-4292. doi: 10.1007/s00259-021-05504-y. Epub 2021 Oct 11. Eur J Nucl Med Mol Imaging. 2021. PMID: 34633509 Free PMC article. Review.

4

Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW.

Huisman LA, Steinkamp PJ, Hillebrands JL, Zeebregts CJ, Linssen MD, Jorritsma-Smit A, Slart RHJA, van Dam GM, Boersma HH. Huisman LA, et al. Among authors: boersma hh. Sci Rep. 2021 Feb 3;11(1):2899. doi: 10.1038/s41598-021-82568-8. Sci Rep. 2021. PMID: 33536498 Free PMC article.

5

Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque.

Jager NA, Westra J, van Dam GM, Teteloshvili N, Tio RA, Breek JC, Slart RH, Boersma H, Low PS, Bijl M, Zeebregts CJ. Jager NA, et al. J Nucl Med. 2012 Aug;53(8):1222-9. doi: 10.2967/jnumed.111.099671. Epub 2012 Jun 29. J Nucl Med. 2012. PMID: 22855837 Free article.

6

Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets.

Jager NA, Wallis de Vries BM, Hillebrands JL, Harlaar NJ, Tio RA, Slart RH, van Dam GM, Boersma HH, Zeebregts CJ, Westra J. Jager NA, et al. Among authors: boersma hh. Mol Imaging Biol. 2016 Apr;18(2):283-91. doi: 10.1007/s11307-015-0882-0. Mol Imaging Biol. 2016. PMID: 26377769 Free PMC article.

7

In vitro imaging of bacteria using ¹⁸F-fluorodeoxyglucose micro positron emission tomography.

Heuker M, Sijbesma JWA, Aguilar Suárez R, de Jong JR, Boersma HH, Luurtsema G, Elsinga PH, Glaudemans AWJM, van Dam GM, van Dijl JM, Slart RHJA, van Oosten M. Heuker M, et al. Among authors: boersma hh. Sci Rep. 2017 Jul 10;7(1):4973. doi: 10.1038/s41598-017-05403-z. Sci Rep. 2017. PMID: 28694519 Free PMC article.

8

Publisher Correction: In vitro imaging of bacteria using ¹⁸F-fluorodeoxyglucose micro positron emission tomography.

Heuker M, Sijbesma JWA, Aguilar Suárez R, de Jong JR, Boersma HH, Luurtsema G, Elsinga PH, Glaudemans AWJM, van Dam GM, van Dijl JM, Slart RHJA, van Oosten M. Heuker M, et al. Among authors: boersma hh. Sci Rep. 2019 Jul 17;9(1):10535. doi: 10.1038/s41598-019-46786-5. Sci Rep. 2019. PMID: 31311991 Free PMC article.

9

VEGF-Targeted Multispectral Optoacoustic Tomography and Fluorescence Molecular Imaging in Human Carotid Atherosclerotic Plaques.

Steinkamp PJ, Vonk J, Huisman LA, Meersma GJ, Diercks GFH, Hillebrands JL, Nagengast WB, Zeebregts CJ, Slart RHJA, Boersma HH, van Dam GM. Steinkamp PJ, et al. Among authors: boersma hh. Diagnostics (Basel). 2021 Jul 7;11(7):1227. doi: 10.3390/diagnostics11071227. Diagnostics (Basel). 2021. PMID: 34359310 Free PMC article.

10

Feasibility of vascular endothelial growth factor imaging in human atherosclerotic plaque using (89)Zr-bevacizumab positron emission tomography.

Golestani R, Zeebregts CJ, Terwisscha van Scheltinga AG, Lub-de Hooge MN, van Dam GM, Glaudemans AW, Dierckx RA, Tio RA, Suurmeijer AJ, Boersma HH, Nagengast WB, Slart RH. Golestani R, et al. Among authors: boersma hh. Mol Imaging. 2013 Jun;12(4):235-43. Mol Imaging. 2013. PMID: 23651501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page